PRESS RELEASE published on 02/10/2026 at 08:00, 13 days 2 hours ago Informations privilégiées / Autres communiqués Vitura sécurise 16.000 m² pour Huawei dans l'immeuble Arcs de Seine à Boulogne-Billancourt, renouvelant des locataires de premier plan. L'actif offre des espaces de travail de qualité avec services hôteliers et certifications environnementales Développement Durable Vitura Bureaux Huawei Arcs De Seine
PRESS RELEASE published on 02/10/2026 at 07:30, 13 days 2 hours ago Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026 Nicox to present NCX 470 Phase 3 data at AGS Annual Meeting 2026 with podium presentations showcasing clinical study results and efficacy of the ophthalmic solution Clinical Study Ophthalmology Nicox NCX 470 AGS Annual Meeting 2026
PRESS RELEASE published on 02/10/2026 at 07:30, 13 days 2 hours ago Nicox : Présentation des données des études de Phase 3 de NCX 470 au congrès annuel 2026 de l’American Glaucoma Society (AGS) Nicox présente les données des études de Phase 3 de NCX 470 au congrès annuel 2026 de l'AGS, démontrant l'efficacité de leur nouveau produit pour le glaucome Ophtalmologie Nicox NCX 470 Études De Phase 3 Congrès AGS
PRESS RELEASE published on 02/10/2026 at 07:30, 13 days 2 hours ago VIEL ET COMPAGNIE : Chiffre d’affaires de 1 266,9 millions d’euros sur l’année 2025 en croissance de 7,4% à cours de change courants -Croissance de 10,7% du chiffre d’affaires à cours de change constants VIEL & Cie enregistre une croissance de 7,4% de son chiffre d’affaires en 2025, atteignant 1 266,9 millions d’euros. Les résultats seront publiés le 27 mars 2026 Résultats Financiers Croissance Euronext Paris Chiffre D’affaires VIEL & Cie
PRESS RELEASE published on 02/10/2026 at 07:30, 13 days 2 hours ago Informations privilégiées / Autres communiqués L'Hôpital national des 15-20 et GenSight Biologics traitent le premier patient dans l'étude REVISE de GS010/LUMEVOQ contre la neuropathie optique héréditaire de Leber en France GenSight Biologics Neuropathie Optique GS010/LUMEVOQ Hôpital Des 15-20 Étude REVISE
PRESS RELEASE published on 02/10/2026 at 07:30, 13 days 2 hours ago Inside Information / Other news releases 15-20 National Hospital and GenSight Biologics treat first patient in GS010/LUMEVOQ® REVISE Study, for Leber Hereditary Optic Neuropathy. Clinical study supported by ANSM and aiming to enroll 14 patients in France GenSight Biologics LHON GS010/LUMEVOQ REVISE Study 15-20 National Hospital
PRESS RELEASE published on 02/10/2026 at 07:00, 13 days 3 hours ago EQS-Adhoc: ams OSRAM post Q4 above mid-point of guidance, delivers EUR 144 m FCF in FY25 and launches EUR 200 m ‘Simplify’ transformation and savings program ams OSRAM posts Q4 above mid-point of guidance, delivers EUR 144 m Free Cash Flow in FY25. Launches EUR 200 m 'Simplify' transformation & program. Strategy update, financial targets, and Q1/FY26 outlook shared. Details on semiconductor BU results & industry dynamics Free Cash Flow Q4 Results Ams OSRAM Semiconductor Business Simplify Program
PRESS RELEASE published on 02/10/2026 at 07:00, 13 days 3 hours ago Waga Energy: Croissance de +23 % des revenus de production de biométhane en 2025 Waga Energy affiche une croissance de +23 % de ses revenus de biométhane en 2025, avec une production de 674 GWh et un CA de 59,6 M€. Le groupe prévoit une hausse de +16 % de son pipeline commercial Croissance Waga Energy Biométhane Revenus Pipeline Commercial
PRESS RELEASE published on 02/10/2026 at 07:00, 13 days 3 hours ago TUI delivers best Q1 performance with Und. EBIT of €77m, growing strongly by +€26m. We reaffirm our FY26 guidance of +7-10% Und. EBIT growth (at CC), driven by expectations for Summer 2026 TUI AG reports best Q1 performance with Und. EBIT of €77m, +€26m YoY growth. Reaffirms FY26 guidance of +7-10% Und. EBIT growth, driven by Summer 2026 expectations TUI AG Q1 Performance FY26 Guidance Und. EBIT Summer 2026
PRESS RELEASE published on 02/10/2026 at 07:00, 13 days 3 hours ago Waga Energy posts a +23% yoy RNG production revenue growth Waga Energy reports a +23% year-on-year growth in RNG production revenue, totaling €52.8m in 2025. Demonstrates industrial capabilities with 35 operational units and growing commercial pipeline Revenue Growth Waga Energy RNG Production Commercial Pipeline Industrial Capabilities
Published on 02/23/2026 at 09:01, 1 hour 8 minutes ago Apex Critical Metals Accepted into U.S. Defense Industrial Base Consortium (DIBC)
Published on 02/23/2026 at 08:45, 1 hour 24 minutes ago AGTech to Help Build One-Stop Trading Services Platform as Hong Kong Gold Exchange Opens for the Year of the Horse
Published on 02/23/2026 at 08:00, 2 hours 9 minutes ago Interim Funding Facility Update Appointment of Stanbic and CBZ as Co Lead Arrangers
Published on 02/22/2026 at 23:45, 10 hours 24 minutes ago Barton Distributes $640,000 in JMEI Tax Credits
Published on 02/21/2026 at 00:45, 2 days 9 hours ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/23/2026 at 09:48, 20 minutes ago Equal Pay Day: Men achieve twice the salary increase of women when changing jobs
Published on 02/23/2026 at 09:05, 1 hour 3 minutes ago Beyond Commitment: Jackery Shares Measurable Progress Through Its Environmental Partnership with Greenspark
Published on 02/23/2026 at 09:05, 1 hour 3 minutes ago Julius Meinl Achieves 100 % Responsibly Selected Coffee, Marking a Major Sustainability Milestone
Published on 02/23/2026 at 09:00, 1 hour 8 minutes ago Original-Research: ZEAL Network SE (von NuWays AG): BUY
Published on 02/23/2026 at 09:00, 1 hour 8 minutes ago Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY
Published on 02/20/2026 at 19:29, 2 days 14 hours ago SFPI GROUP: bilan du contrat de liquidité S2 S025